{"transactions":[{"id":1055920,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":76104,"kind":"person","name":"Leyman Barbara","position":1,"cik":"0002028309","reported_name":"Leyman Barbara","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Restricted Stock Units (RSUs)","published_at":"2025-08-26T21:21:26.000Z","date":"2025-07-08","kind":"exercise","planned":false,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest as to 1/4th of the total award annually beginning on July 8, 2025, subject to the reporting person's continued service to the Issuer through each vesting date."}],"balance_after":75000,"derivative":{"expiration_date":"2028-07-08","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001415889-25-023084","document":"form4-08272025_010822.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2028309/000141588925023084/form4-08272025_010822.xml","form_type":"4"}},{"id":1055919,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":76104,"kind":"person","name":"Leyman Barbara","position":1,"cik":"0002028309","reported_name":"Leyman Barbara","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-08-26T21:21:26.000Z","date":"2025-07-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":8944,"price":0.78,"value":6976.32,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of restricted stock units; does not represent a sale by the reporting person."}],"balance_after":16056,"source":{"system":"sec-edgar","filing":"0001415889-25-023084","document":"form4-08272025_010822.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2028309/000141588925023084/form4-08272025_010822.xml","form_type":"4"}},{"id":1055918,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":76104,"kind":"person","name":"Leyman Barbara","position":1,"cik":"0002028309","reported_name":"Leyman Barbara","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-08-26T21:21:26.000Z","date":"2025-07-08","kind":"exercise","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001415889-25-023084","document":"form4-08272025_010822.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2028309/000141588925023084/form4-08272025_010822.xml","form_type":"4"}},{"id":1175808,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":76104,"kind":"person","name":"Leyman Barbara","position":1,"cik":"0002028309","reported_name":"Leyman Barbara","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Dev. Officer"}}],"security":"Restricted Stock Units (RSUs)","published_at":"2025-04-08T16:09:35.000Z","date":"2025-04-04","kind":"grant","planned":false,"acquired":true,"shares":84500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest as to 1/4th of the total award annually beginning on March 2, 2026, subject to the reporting person's provision of service to the issuer on each vesting date."}],"balance_after":84500,"derivative":{"expiration_date":"2029-03-02","underlying":"Common Stock","underlying_shares":84500},"source":{"system":"sec-edgar","filing":"0001415889-25-010383","document":"form4-04082025_080432.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2028309/000141588925010383/form4-04082025_080432.xml","form_type":"4"}},{"id":1175807,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":76104,"kind":"person","name":"Leyman Barbara","position":1,"cik":"0002028309","reported_name":"Leyman Barbara","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Dev. Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-04-08T16:09:35.000Z","date":"2025-04-04","kind":"grant","planned":false,"acquired":true,"shares":91000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 2.0833% of the total award monthly, beginning on May 4, 2025, with 100% of the award being vested and exercisable on April 4, 2029, subject to the reporting person's provision of service to the issuer on each vesting date."}],"balance_after":91000,"derivative":{"exercise_price":0.55,"expiration_date":"2035-04-04","underlying":"Common Stock","underlying_shares":91000},"source":{"system":"sec-edgar","filing":"0001415889-25-010383","document":"form4-04082025_080432.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2028309/000141588925010383/form4-04082025_080432.xml","form_type":"4"}},{"id":1457037,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":76104,"kind":"person","name":"Leyman Barbara","position":1,"cik":"0002028309","reported_name":"Leyman Barbara","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Dev. Officer"}}],"security":"Restricted Stock Units (RSUs)","published_at":"2024-07-10T16:11:28.000Z","date":"2024-07-08","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest as to 1/4th of the total award annually beginning on July 8, 2025, subject to the reporting person's continued service to the issuer through each vesting date."}],"balance_after":100000,"derivative":{"expiration_date":"2028-07-08","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001415889-24-019462","document":"form4-07102024_080725.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2028309/000141588924019462/form4-07102024_080725.xml","form_type":"4"}},{"id":1457036,"issuer":{"id":5797,"kind":"organization","name":"SUTRO BIOPHARMA, INC.","symbol":"STRO"},"owners":[{"id":76104,"kind":"person","name":"Leyman Barbara","position":1,"cik":"0002028309","reported_name":"Leyman Barbara","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Dev. Officer"}}],"security":"Stock Option (Right to Buy Common Stock)","published_at":"2024-07-10T16:11:28.000Z","date":"2024-07-08","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 25% of the total award on July 8, 2025, then in equal monthly installments over the following three years, subject to the reporting person's continued service to the issuer on each vesting date."}],"balance_after":125000,"derivative":{"exercise_price":3.04,"expiration_date":"2034-07-08","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001415889-24-019462","document":"form4-07102024_080725.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2028309/000141588924019462/form4-07102024_080725.xml","form_type":"4"}}]}